Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment resumes in phase I Reolysin study

May 9, 2003

Novel inhibitors of VEGFR, PDGFR and/or c-kit kinase under study at Sugen

May 9, 2003

CDK inhibitors in early development at Bayer

May 9, 2003

Schering and Pharmacopeia present new CXC antagonists for cancer and other uses

May 9, 2003

Polycyclic antitumor compounds newly discovered at Roche

May 9, 2003

Schering AG and Astex enter drug discovery collaboration

May 8, 2003

Updated phase II results for Tocosol Paclitaxel

May 8, 2003

Progress made in Bexxar review

May 8, 2003

Introgen gains license to fus1 anticancer gene

May 8, 2003

Viventia's first armed antibodies to enter phase I clinical testing

May 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...